BIOMAT Database Logo BIOMAT Database Logo

[Results of treatment for severe acquired aplastic anemia in children]. 1995

M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
Klinika Hematologii i Chorób Rozrostowych Dzieci Akademii Medycznej w Warszawie.

The authors evaluated results of treatment of 106 children with acquired aplastic anemia. The patients were divided into 3 groups depending on the severity of their disease. Thirty-nine patients were classified as very severe, 30 as severe and 37 as non-severe according to the modified Camitta criteria. Among them, 47 children were treated with oxymetholone and prednisolone. In this group 32 died. Antilymphocyte globulin (ALG) was given to 48 patients and 20 received cyclosporin A (CsA). The results obtained by these two methods are nearly the same and 5 year survival was 61% and 59% respectively. Bone marrow was transplanted in only one child, who is still in complete remission. Statistical analysis showed a steady increase in incidence of aplastic anemia in the years 1987-1989, which might coincide with the Czarnobyl explosion. However, further research is required to prove this point.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010110 Oxymetholone A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed) Hydroxymetholone,Anadrol,Anapolon 50,Oxymethalone,Oxymetholone, (17 beta)-Isomer,Oxymetholone, (5 alpha,17 alpha)-Isomer
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
Treatment of acquired severe aplastic anemia.
January 1989, The American journal of pediatric hematology/oncology,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
[Treatment of severe acquired aplastic anemia].
January 1995, Nordisk medicin,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
The treatment of severe acquired aplastic anemia.
June 1995, Blood,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
Treatment of acquired aplastic anemia in children.
April 2012, Hematology (Amsterdam, Netherlands),
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
Acquired aplastic anemia in children.
December 2013, Pediatric clinics of North America,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
Acquired aplastic anemia in children.
February 1969, Texas medicine,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
Immunosuppressive treatment in children with acquired aplastic anemia.
June 2012, Turkish journal of haematology : official journal of Turkish Society of Haematology,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
[Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
November 2006, Zhonghua er ke za zhi = Chinese journal of pediatrics,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
[Treatment strategy for acquired aplastic anemia].
January 2018, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Ochocka, and M Karwacki, and M Matysiak, and J Armata, and A Dłuzniewska, and J Bogusławska-Jaworska, and J Pejcz, and J Kowalczyk, and S Skomra, and U Radwańska
Updated Guidelines for the Treatment of Acquired Aplastic Anemia in Children.
June 2018, Current oncology reports,
Copied contents to your clipboard!